1
|
Gutierrez-Ontalvilla P, Vidal L, Ruiz-Valls A, Iborra M. Letter to the Editor on The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate-Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study. Aesthetic Plast Surg 2023; 47:66-68. [PMID: 35689103 DOI: 10.1007/s00266-022-02960-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Accepted: 05/17/2022] [Indexed: 11/01/2022]
Affiliation(s)
- P Gutierrez-Ontalvilla
- Department of Plastic and Reconstructive Surgery, Hospital University La Fe, Avda Fernando Abril Martorell 106, 46026, Valencia, Spain.
| | - L Vidal
- Fidia Farmacéutica S.L.U, Barcelona, Spain
| | - A Ruiz-Valls
- Department of Plastic and Reconstructive Surgery, Hospital University La Fe, Avda Fernando Abril Martorell 106, 46026, Valencia, Spain
| | - M Iborra
- Unit of Inflammatory Bowel Disease, Department of Digestive Medicine, Hospital University La Fe, Valencia, Spain
| |
Collapse
|
2
|
Lyons S, Baile Pomares P, Vidal L, McGarry K, Morrin A, Brougham DF. Surface Potential Modulation in Boronate-Functionalized Magnetic Nanoparticles Reveals Binding Interactions: Toward Magnetophoretic Capture/Quantitation of Sugars from Extracellular Matrix. Langmuir 2023. [PMID: 37235552 DOI: 10.1021/acs.langmuir.3c00462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Phenylboronic acids (BAs) are important synthetic receptors that bind reversibly to cis-diols enabling their use in molecular sensing. When conjugated to magnetic iron oxide nanoparticles, BAs have potential for application in separations and enrichment. Realizing this will require a new understanding of their inherent binding modes and measurement of their binding capacity and their stability in/extractability from complex environments. In this work, 3-aminophenylboronic acid was functionalized to superparamagnetic iron oxide nanoparticles (MNPs, core diameter 8.9 nm) to provide stable aqueous suspensions of functionalized particles (BA-MNPs). The progress of sugar binding and its impact on BA-MNP colloidal stability were monitored through the pH-dependence of hydrodynamic size and zeta potential during incubation with a range of saccharides. This provided the first direct observation of boronate ionization pKa in grafted BA, which in the absence of sugar shifted to a slightly more basic pH than free BA. On exposure to sugar solutions under MNP-limiting conditions, pKa moved progressively to lower pH as maximum capacity was gradually attained. The pKa shift is shown to be greater for sugars with greater BA binding affinity, and on-particle sugar exchange effects were inferred. Colloidal dispersion of BA-MNPs after binding was shown for all sugars at all pHs studied, which enabled facile magnetic extraction of glucose from agarose and cultured extracellular matrix expanded in serum-free media. Bound glucose, quantified following magnetophoretic capture, was found to be proportional to the solution glucose content under glucose-limiting conditions expected for the application. The implications for the development of MNP-immobilized ligands for selective magnetic biomarker capture and quantitation from the extracellular environment are discussed.
Collapse
Affiliation(s)
- Stephen Lyons
- SFI Insight Centre for Data Analytics; National Centre for Sensor Research; School of Chemical Sciences, Dublin City University, Dublin 9, Ireland
| | - Paola Baile Pomares
- Departamento de Química Analítica, Nutrición y Bromatología, Instituto Universitario de Materiales, Universidad de Alicante, PO Box 99, 03080 Alicante, Spain
| | - Lorena Vidal
- Departamento de Química Analítica, Nutrición y Bromatología, Instituto Universitario de Materiales, Universidad de Alicante, PO Box 99, 03080 Alicante, Spain
| | - Katie McGarry
- School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
| | - Aoife Morrin
- SFI Insight Centre for Data Analytics; National Centre for Sensor Research; School of Chemical Sciences, Dublin City University, Dublin 9, Ireland
| | - Dermot F Brougham
- School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
| |
Collapse
|
3
|
Ripoll L, Rayos J, Aguirre MÁ, Vidal L, Canals A. Natural deep eutectic solvent-based microextraction for mercury speciation in water samples. Anal Bioanal Chem 2023:10.1007/s00216-023-04610-0. [PMID: 36872410 PMCID: PMC10328898 DOI: 10.1007/s00216-023-04610-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 01/30/2023] [Accepted: 02/13/2023] [Indexed: 03/07/2023]
Abstract
A new natural deep eutectic solvent (NADES)-based analytical method for mercury speciation in water samples is presented. A NADES (i.e., decanoic acid:DL-menthol in a molar ratio of 1:2) is used as an environmentally friendly extractant for separation and preconcentration using dispersive liquid-liquid microextraction before LC-UV-Vis. Under optimal extraction conditions (i.e., NADES volume, 50 µL; sample pH, 12; volume of the complexing agent, 100 µL; extraction time, 3 min; centrifugation speed, 3000 rpm; and centrifugation time, 3 min), the limit of detection values were 0.9 µg L-1 for the organomercurial species and 3 µg L-1 for Hg2+, which had a slightly higher value. The relative standard deviation (RSD, n = 6) has been evaluated at two concentration levels (25 and 50 µg L-1) obtaining values for all the mercury complexes within the range of 6-12% and 8-12%, respectively. The trueness of the methodology has been evaluated using five real water samples from four different sources (i.e., tap, river, lake, and wastewater). The recovery tests have been performed in triplicate obtaining relative recoveries between 75 and 118%, with RSD (n = 3) between 1 and 19%, for all the mercury complexes in surface water samples. However, wastewater sample showed a significant matrix effect (recoveries ranged between 45 and 110%), probably due to the high amount of organic matter. Finally, the greenness of the method has also been evaluated by the analytical greenness metric for sample preparation (i.e., AGREEprep).
Collapse
Affiliation(s)
- Laura Ripoll
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, Alicante, 03080, Spain
| | - Javier Rayos
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, Alicante, 03080, Spain
| | - Miguel Ángel Aguirre
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, Alicante, 03080, Spain
| | - Lorena Vidal
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, Alicante, 03080, Spain.
| | - Antonio Canals
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, Alicante, 03080, Spain.
| |
Collapse
|
4
|
Alustiza M, Ripoll L, Canals A, Murcia O, Martínez-Roca A, García-Heredia A, Giner-Calabuig M, Jover R, Vidal L. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers. Clin Chim Acta 2023; 542:117273. [PMID: 36863694 DOI: 10.1016/j.cca.2023.117273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 02/24/2023] [Accepted: 02/25/2023] [Indexed: 03/04/2023]
Abstract
INTRODUCTION Population-based fecal tests for colorectal cancer (CRC) screening have shown to reduce mortality thanks to the early detection of the disease. However, currently available fecal tests are limited in their sensitivity and specificity. Our aim is to look for volatile organic compounds in fecal samples as biomarkers for CRC detection. MATERIAL AND METHODS Eighty participants were included; 24 had adenocarcinoma, 24 had adenomatous polyps and 32 presented no neoplasms. Fecal samples were collected 48 h preceding the colonoscopy from all participants, except CRC patient samples that were collected after 3-4 weeks from the colonoscopy. Magnetic headspace adsorptive extraction (Mag-HSAE) followed by thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS) was performed on stool samples to identify volatile organic compounds as biomarkers. RESULTS p-Cresol was significantly more abundant in the cancer samples (P < 0.001) with an area under the curve (AUC) of 0.85 (CI 95%; 0.737-0.953), having a sensitivity and specificity of 83% and 82%, respectively. In addition, 3(4H)-dibenzofuranone,4a,9b-dihydro-8,9b-dimethyl- (3(4H)-DBZ) was also more abundant in the cancer samples (P < 0.001) with an AUC of 0.77 (CI 95%; 0.635-0.905), sensitivity of 78% and specificity of 75%. When combined (p-cresol and 3(4H)-DBZ), the AUC was 0.86, sensitivity 87% and specificity 79%. p-Cresol also appeared to be promising as a biomarker for pre-malignant lesions with an AUC of 0.69 (CI 95%; 0.534-0.862), sensitivity 83% and specificity 63%, P = 0.045. CONCLUSIONS Volatile organic compounds emitted from feces and determined by a sensitive analytical methodology (Mag-HSAE-TD-GC-MS), employing a magnetic graphene oxide as extractant phase, could be used as a potential screening technology for CRC and pre-malignant lesions.
Collapse
Affiliation(s)
- Miren Alustiza
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - Laura Ripoll
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, 03080 Alicante, Spain
| | - Antonio Canals
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, 03080 Alicante, Spain
| | - Oscar Murcia
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Servicio de Medicina Digestiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - Alejandro Martínez-Roca
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - Anabel García-Heredia
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - Mar Giner-Calabuig
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
| | - Rodrigo Jover
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Servicio de Medicina Digestiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
| | - Lorena Vidal
- Laboratorio de Investigación, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, 03080 Alicante, Spain.
| |
Collapse
|
5
|
Martínez-Gil N, Kutsyr O, Noailles A, Fernández-Sánchez L, Vidal L, Sánchez-Sáez X, Sánchez-Castillo C, Lax P, Cuenca N, García AG, Maneu V. Purinergic Receptors P2X7 and P2X4 as Markers of Disease Progression in the rd10 Mouse Model of Inherited Retinal Dystrophy. Int J Mol Sci 2022; 23:ijms232314758. [PMID: 36499084 PMCID: PMC9739106 DOI: 10.3390/ijms232314758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2022] [Revised: 11/18/2022] [Accepted: 11/21/2022] [Indexed: 11/29/2022] Open
Abstract
The purinergic receptor P2X7 (P2X7R) is implicated in all neurodegenerative diseases of the central nervous system. It is also involved in the retinal degeneration associated with glaucoma, age-related macular degeneration, and diabetic retinopathy, and its overexpression in the retina is evident in these disorders. Retinitis pigmentosa is a progressive degenerative disease that ultimately leads to blindness. Here, we investigated the expression of P2X7R during disease progression in the rd10 mouse model of RP. As the purinergic receptor P2X4 is widely co-expressed with P2X7R, we also studied its expression in the retina of rd10 mice. The expression of P2X7R and P2X4R was examined by immunohistochemistry, flow cytometry, and western blotting. In addition, we analyzed retinal functionality by electroretinographic recordings of visual responses and optomotor tests and retinal morphology. We found that the expression of P2X7R and P2X4R increased in rd10 mice concomitant with disease progression, but with different cellular localization. Our findings suggest that P2X7R and P2X4R might play an important role in RP progression, which should be further analyzed for the pharmacological treatment of inherited retinal dystrophies.
Collapse
Affiliation(s)
- Natalia Martínez-Gil
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Oksana Kutsyr
- Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 Alicante, Spain
| | - Agustina Noailles
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Laura Fernández-Sánchez
- Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 Alicante, Spain
| | - Lorena Vidal
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Xavier Sánchez-Sáez
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Carla Sánchez-Castillo
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Pedro Lax
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Nicolás Cuenca
- Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, 03690 Alicante, Spain
| | - Antonio G. García
- Departamento de Farmacología y Terapéutica, Instituto-Fundación Teófilo Hernando, Facultad de Medicina, Universidad Autónoma de Madrid, 28029 Madrid, Spain
- Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain
| | - Victoria Maneu
- Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, 03690 Alicante, Spain
- Correspondence:
| |
Collapse
|
6
|
Gutierrez-Ontalvilla P, Giner F, Vidal L, Iborra M. The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate-Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study. Aesthetic Plast Surg 2022; 46:2469-2479. [PMID: 35048150 DOI: 10.1007/s00266-021-02718-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 12/06/2021] [Indexed: 12/24/2022]
Abstract
BACKGROUND The first-line treatment for vulvar lichen sclerosus (VLS) is 3 months of topical corticosteroid therapy. However, limited evidence is available concerning the use of fat grafting and platelet-rich plasma as a second-line treatment for patients who do not respond to first-line treatment. METHODS This prospective single-center randomized pilot trial included 20 patients with a clinical and histological diagnosis of moderate to severe VLS. The patients in the treatment group (TG) received two infiltrations (at 3-month intervals) of nanofat mixed with platelet-rich plasma (PRP) into the vulvar area, while the control group (CG) received standard topical corticosteroid therapy. Fat was aspirated from the medial thigh or lower abdomen regions. Microfat was obtained after centrifugation and was emulsified to obtain a nanofat suspension. Treatment efficacy was determined by measuring changes in the vulvar skin elasticity, histopathology, and clinical signs, symptoms, and patient quality of life at after 1 year. RESULTS A total of 19 patients were finally assessed (9 TG and 10 CG). At the end of the study (1 year), there had been no significant improvement in vulvar skin elasticity. However, patients in the TG showed a significant improvement in their symptoms (itching, pain, burning, and dyspareunia) and clinical signs (cervical erosions, fissures, stenosis, and leukoderma). Analysis of skin biopsies revealed a significant decrease in all inflammatory cell types in the TG. No adverse events related to the autologous treatment were recorded. CONCLUSIONS Compared with topical corticosteroids, two infiltrations delivered 3 months apart decreased the inflammation of the vulva and improved most of the clinical signs and symptoms associated with VLS. Nonetheless, no improvement in vulvar skin elasticity was derived from the autologous treatment. LEVEL OF EVIDENCE I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Collapse
Affiliation(s)
- P Gutierrez-Ontalvilla
- Department of Plastic and Reconstructive Surgery, Hospital University La Fe, Avda Fernando Abril Martorell 106, 46026, Valencia, Spain.
| | - F Giner
- Department of Histology, Hospital University La Fe, Valencia, Spain
| | - L Vidal
- Fidia Farmacéutica S.L.U, Barcelona, Spain
| | - M Iborra
- Department of Digestive Medicine, Unit of inflammatory bowel disease, Hospital University La Fe, Valencia, Spain
| |
Collapse
|
7
|
Frenel JS, Kim JW, Aryal N, Asher R, Berton D, Vidal L, Pautier P, Ledermann JA, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon TW, Tamura K, Sonke GS, Freimund AE, Lee CK, Pujade-Lauraine E. Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Ann Oncol 2022; 33:1021-1028. [PMID: 35772665 DOI: 10.1016/j.annonc.2022.06.011] [Citation(s) in RCA: 40] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 06/16/2022] [Accepted: 06/20/2022] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND In the SOLO2 trial (ENGOT Ov-21; NCT01874353), maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer (PSROC) and BRCA mutation significantly improved progression-free survival (PFS) and prolonged overall survival (OS). Following disease progression on olaparib, efficacy of subsequent chemotherapy remains unknown. PATIENTS AND METHODS We conducted a post-hoc hypothesis-generating analysis of SOLO2 data to determine the efficacy of different chemotherapy regimens following RECIST disease progression in patients who received olaparib or placebo. We evaluated time to second progression (TTSP) calculated from the date of RECIST progression to the next progression/death. RESULTS The study population comprised 147 patients who received chemotherapy as their first subsequent treatment after RECIST progression. Of these, 69 (47%) and 78 (53%) were originally randomized to placebo and olaparib arms, respectively. In the placebo-treated cohort, 27/69 and 42/69 received non-platinum and platinum-based chemotherapy, respectively, compared with 24/78 and 54/78, respectively, in the olaparib-treated cohort. Among patients treated with chemotherapy (N = 147), TTSP was significantly longer in the placebo than in the olaparib arm: 12.1 versus 6.9 months [hazard ratio (HR) 2.17, 95% confidence interval (CI) 1.47-3.19]. Similar result was obtained on multivariable analysis adjusting for prognostic factors at RECIST progression (HR 2.13, 95% CI 1.41-3.22). Among patients treated with platinum-based chemotherapy (n = 96), TTSP was significantly longer in the placebo arm: 14.3 versus 7.0 months (HR 2.89, 95% CI 1.73-4.82). Conversely, among patients treated with non-platinum-based chemotherapy (n = 51), the TTSP was comparable in the placebo and olaparib arms: 8.3 versus 6.0 months (HR 1.58, 95% CI 0.86-2.90). CONCLUSIONS Following progression from maintenance olaparib in the recurrent setting, the efficacy of platinum-based subsequent chemotherapy seems to be reduced in BRCA1/2-mutated patients with PSROC compared to patients not previously receiving poly (ADP-ribose) polymerase inhibitors (PARPi). The optimal strategy for patients who relapse after PARPi is an area of ongoing research.
Collapse
Affiliation(s)
- J S Frenel
- Institut de Cancerologie de l'Ouest, GINECO, GINEGEPS, Centre René Gauducheau, Saint-Herblain, France.
| | - J W Kim
- Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - N Aryal
- NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia
| | - R Asher
- NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia
| | - D Berton
- Institut de Cancerologie de l'Ouest, GINECO, GINEGEPS, Centre René Gauducheau, Saint-Herblain, France
| | - L Vidal
- GEICO & H Clínic de Barcelona, Barcelona, Spain
| | - P Pautier
- GINECO & Gustave Roussy Cancer Center, Villejuif, France
| | | | - R T Penson
- Massachusetts General Hospital, Boston, USA
| | - A M Oza
- Princess Margaret Cancer Centre, Toronto, Canada
| | - J Korach
- ISGO & Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel
| | - T Huzarski
- Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
| | - S Pignata
- MITO & Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Naples, Italy
| | - N Colombo
- MaNGO & European Institute of Oncology IRCCS and University of Milan-Bicocca, Milano, Italy
| | - T W Park-Simon
- AGO & Medical School, Department of Gynecologic Oncology, Hannover, Hannover, Germany
| | - K Tamura
- Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - G S Sonke
- DGOG & Netherlands Cancer Institute, Amsterdam, Netherlands
| | - A E Freimund
- Peter MacCallum Cancer Centre, Melbourne, Australia
| | - C K Lee
- NHMRC CTC Centre, University of Sydney, Camperdown, Sydney, Australia
| | | |
Collapse
|
8
|
Montazeri S, De la Garza-Ramos C, Lewis A, Lewis J, LeGout J, Sella D, Paz-Fumagalli R, Devcic Z, Ritchie C, Frey G, Vidal L, McKinney J, Toskich B. Abstract No. 197 Predictors of complete pathologic necrosis in hepatocellular carcinoma treated with yttrium-90 radiation segmentectomy prior to liver transplantation: an explant analysis of 75 tumors. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
O'Kelly B, Vidal L, Avramovic G, Broughan J, Cotter AG, Cullen W, McHugh T, O'Gorman T, Woo J, Lambert JS. Predictors and Outcomes for COVID-19 Re-Admissions in the Anticipate Cohort. Ir Med J 2022; 115:599. [PMID: 35696289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Aims To describe readmissions of hospitalised patients with COVID-19, define predictors of readmission and explore the long term outcomes using the SF-12 score compared to patients who were not readmitted and those not hospitalised. Methods A single centre retrospective in North Inner-City Dublin. Recruitment was done through a COVID follow up clinic. Predictors of readmission and SF-12 scores at two timepoints post follow up at median 3 months and 12 months. Results Seventy (45%) participants were admitted, with a median age of 49.5 years (IQR 41.3-56.9), 36(51%) of whom were female. Unscheduled readmissions at ≤30 days in COVID-19 patients were 9(12.9%) and length of stay was four days (IQR 2-5). Readmissions were due to ongoing symptoms(n=9(64.3%)) or new complications(n=5(35.7%)). Mechanical ventilation and having symptoms of nausea and vomiting on index admission were predictive of readmission. (p=0.002). SF-12 scores at one year of readmitted patients were not different to patients who were never admitted at median one year follow up, p=.089. Conclusions Most readmissions were of short duration. Early follow up of patients post MV or who had nausea and vomiting on index admission should be prioritised. Wellbeing of readmitted patients was not different to those never hospitalised, at one year.
Collapse
Affiliation(s)
- B O'Kelly
- Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland
- Centre for Experimental Pathogen Host Research, University College Dublin, Dublin 4, Ireland
| | - L Vidal
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - G Avramovic
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - J Broughan
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - A G Cotter
- Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland
- Centre for Experimental Pathogen Host Research, University College Dublin, Dublin 4, Ireland
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - W Cullen
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - T McHugh
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - T O'Gorman
- School of Medicine, University College Dublin, Dublin 4, Ireland
| | - J Woo
- Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland
| | - J S Lambert
- Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin 7, Ireland
- School of Medicine, University College Dublin, Dublin 4, Ireland
| |
Collapse
|
10
|
Chetcuti K, Chilingulo C, Goyal MS, Vidal L, O'Brien NF, Postels DG, Seydel KB, Taylor TE. Implementation of a Low-Field Portable MRI Scanner in a Resource-Constrained Environment: Our Experience in Malawi. AJNR Am J Neuroradiol 2022; 43:670-674. [PMID: 35450856 PMCID: PMC9089250 DOI: 10.3174/ajnr.a7494] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 03/03/2022] [Indexed: 11/07/2022]
Abstract
Low-field, portable MR imaging may expedite patient management in the setting of critical illness. We successfully implemented low-field MR imaging at the Queen Elizabeth Central Hospital in Malawi; a low-resource setting. We present our experience of low-field, portable MR imaging start-up and use in Malawi; the first of its kind in Sub-Saharan Africa, together with complementary troubleshooting mechanisms that may be used especially in similar resource-constrained contexts.
Collapse
Affiliation(s)
- K Chetcuti
- From the Department of Paediatrics and Child Health (K.C.)
| | - C Chilingulo
- Blantyre Malaria Project (C.C., N.F.O., D.G.P., K.B.S., T.E.T.), Kamuzu University of Health Sciences, Blantyre, Malawi.,Department of Radiology (C.C.), Queen Elizabeth Central Hospital, Blantyre, Malawi
| | - M S Goyal
- Mallinckrodt Institute of Radiology (M.S.G.), Washington University School of Medicine, St. Louis, Missouri
| | - L Vidal
- Division of Neuroradiology (L.V.), Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - N F O'Brien
- Blantyre Malaria Project (C.C., N.F.O., D.G.P., K.B.S., T.E.T.), Kamuzu University of Health Sciences, Blantyre, Malawi.,Division of Critical Care Medicine (N.F.O.), Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio
| | - D G Postels
- Blantyre Malaria Project (C.C., N.F.O., D.G.P., K.B.S., T.E.T.), Kamuzu University of Health Sciences, Blantyre, Malawi.,Department of Neurology (D.G.P.), George Washington University/Children's National Medical Center, Washington, DC
| | - K B Seydel
- Blantyre Malaria Project (C.C., N.F.O., D.G.P., K.B.S., T.E.T.), Kamuzu University of Health Sciences, Blantyre, Malawi.,Department of Osteopathic Medical Specialties (K.B.S., T.E.T.), College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan
| | - T E Taylor
- Blantyre Malaria Project (C.C., N.F.O., D.G.P., K.B.S., T.E.T.), Kamuzu University of Health Sciences, Blantyre, Malawi.,Department of Osteopathic Medical Specialties (K.B.S., T.E.T.), College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan
| |
Collapse
|
11
|
Alcántara I, Somma A, Chalar G, Fabre A, Segura A, Achkar M, Arocena R, Aubriot L, Baladán C, Barrios M, Bonilla S, Burwood M, Calliari DL, Calvo C, Capurro L, Carballo C, Céspedes-Payret C, Conde D, Corrales N, Cremella B, Crisci C, Cuevas J, De Giacomi S, De León L, Delbene L, Díaz I, Fleitas V, González-Bergonzoni I, González-Madina L, González-Piana M, Goyenola G, Gutiérrez O, Haakonsson S, Iglesias C, Kruk C, Lacerot G, Langone J, Lepillanca F, Lucas C, Martigani F, Martínez de la Escalera G, Meerhoff M, Nogueira L, Olano H, Pacheco JP, Panario D, Piccini C, Quintans F, Teixeira de Mello F, Terradas L, Tesitore G, Vidal L, García-Rodríguez F. A reply to "Relevant factors in the eutrophication of the Uruguay River and the Río Negro". Sci Total Environ 2022; 818:151854. [PMID: 34826482 DOI: 10.1016/j.scitotenv.2021.151854] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Revised: 11/02/2021] [Accepted: 11/17/2021] [Indexed: 06/13/2023]
Abstract
A recent paper by Beretta-Blanco and Carrasco-Letelier (2021) claims that agricultural eutrophication is not one of the main causes for cyanobacterial blooms in rivers and artificial reservoirs. By combining rivers of markedly different hydrological characteristics e.g., presence/absence and number of dams, river discharge and geological setting, the study speculates about the role of nutrients for modulating phytoplankton chlorophyll-a. Here, we identified serious flaws, from erratic and inaccurate data manipulation. The study did not define how erroneous original dataset values were treated, how the variables below the detection/quantification limit were numerically introduced, lack of mandatory variables for river studies such as flow and rainfall, arbitrary removal of pH > 7.5 values (which were not outliers), and finally how extreme values of other environmental variables were included. In addition, we identified conceptual and procedural mistakes such as biased construction/evaluation of model prediction capability. The study trained the model using pooled data from a short restricted lotic section of the (large) Uruguay River and from both lotic and reservoir domains of the Negro River, but then tested predictability within the (small) Cuareim River. Besides these methodological considerations, the article shows misinterpretations of the statistical correlation of cause and effect neglecting basic limnological knowledge of the ecology of harmful algal blooms (HABs) and international research on land use effects on freshwater quality. The argument that pH is a predictor variable for HABs neglects overwhelming basic paradigms of carbon fluxes and change in pH because of primary productivity. As a result, the article introduces the notion that HABs formation are not related to agricultural land use and water residence time and generate a great risk for the management of surface waterbodies. This reply also emphasizes the need for good practices of open data management, especially for public databases in view of external reproducibility.
Collapse
Affiliation(s)
- I Alcántara
- Ud. Bioestadística, Departamento de Salud Pública, Facultad de Veterinaria, Universidad de la República, Montevideo, Uruguay
| | - A Somma
- Polo de Ecología Fluvial, CENUR Litoral Norte sede Paysandú, Universidad de la República, Paysandú, Uruguay; Unidad Usinas de Montevideo, Área Tratamiento - Obras Sanitarias del Estado, Aguas Corrientes, Canelones, Uruguay
| | - G Chalar
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - A Fabre
- ITR Suroeste, Universidad Tecnológica, La Paz, Colonia, Uruguay
| | - A Segura
- Modelización y Análisis de Recursos Naturales, Centro Universitario Regional del Este, Universidad de la República, Rocha, Uruguay
| | - M Achkar
- LDSGAT, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - R Arocena
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - L Aubriot
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - C Baladán
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - M Barrios
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - S Bonilla
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - M Burwood
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - D L Calliari
- Sección Oceanografía y Ecología Marina, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - C Calvo
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - L Capurro
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - C Carballo
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - C Céspedes-Payret
- UNCIEP, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - D Conde
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - N Corrales
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - B Cremella
- Laboratory of Environmental Analysis, Université de Sherbrooke, Sherbrooke, Quebec, Canada
| | - C Crisci
- Modelización y Análisis de Recursos Naturales, Centro Universitario Regional del Este, Universidad de la República, Rocha, Uruguay
| | - J Cuevas
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - S De Giacomi
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - L De León
- Ministerio de Ambiente - Dirección Nacional de Calidad y Evaluación Ambiental, Uruguay
| | - L Delbene
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - I Díaz
- LDSGAT, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - V Fleitas
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - I González-Bergonzoni
- Polo de Ecología Fluvial, CENUR Litoral Norte sede Paysandú, Universidad de la República, Paysandú, Uruguay
| | - L González-Madina
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay; Unidad Usinas de Montevideo, Área Tratamiento - Obras Sanitarias del Estado, Aguas Corrientes, Canelones, Uruguay
| | - M González-Piana
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - G Goyenola
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - O Gutiérrez
- UNCIEP, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - S Haakonsson
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - C Iglesias
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - C Kruk
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay; Modelización y Análisis de Recursos Naturales, Centro Universitario Regional del Este, Universidad de la República, Rocha, Uruguay
| | - G Lacerot
- Ecología Funcional de Sistemas Acuáticos, Centro Universitario Regional del Este, Universidad de la República, Uruguay
| | - J Langone
- Unidad Usinas de Montevideo, Área Tratamiento - Obras Sanitarias del Estado, Aguas Corrientes, Canelones, Uruguay
| | - F Lepillanca
- Departamento de Microbiología, Instituto de Investigaciones Biológicas Clemente Estable, Ministerio de Educación y Cultura, Montevideo, Uruguay
| | - C Lucas
- Polo de Ecología Fluvial, CENUR Litoral Norte sede Paysandú, Universidad de la República, Paysandú, Uruguay
| | - F Martigani
- Área Hidrobiología, Gerencia de Gestión de Laboratorios, OSE, Montevideo, Uruguay
| | - G Martínez de la Escalera
- Departamento de Microbiología, Instituto de Investigaciones Biológicas Clemente Estable, Ministerio de Educación y Cultura, Montevideo, Uruguay
| | - M Meerhoff
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay; Department of Biosciences, Aarhus University, Silkeborg, Denmark
| | - L Nogueira
- Unidad Usinas de Montevideo, Área Tratamiento - Obras Sanitarias del Estado, Aguas Corrientes, Canelones, Uruguay
| | - H Olano
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - J P Pacheco
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - D Panario
- UNCIEP, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - C Piccini
- Departamento de Microbiología, Instituto de Investigaciones Biológicas Clemente Estable, Ministerio de Educación y Cultura, Montevideo, Uruguay
| | - F Quintans
- Sección Limnología, IECA, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay
| | - F Teixeira de Mello
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - L Terradas
- UNCIEP, IECA, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
| | - G Tesitore
- Departamento de Ecología y Gestión Ambiental, Centro Universitario Regional del Este, Universidad de la República, Maldonado, Uruguay
| | - L Vidal
- Área Hidrobiología, Gerencia de Gestión de Laboratorios, OSE, Montevideo, Uruguay
| | - F García-Rodríguez
- Departamento de Geociencias, Centro Universitario Regional del Este, Universidad de la República, Rocha, Uruguay; Instituto de Oceanografia, Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil.
| |
Collapse
|
12
|
Todorova S, Blin J, Naydenov A, Lebeau B, Karashanova D, Kolev H, Gaudin P, Velinova R, Vidal L, Michelin L, Josien L, Filkova D, Ivanova I, Dotzeva A, Tenchev K. Co-Mn oxides supported on hierarchical macro-mesoporous silica for CO and VOCs oxidation. Catal Today 2021. [DOI: 10.1016/j.cattod.2020.01.019] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
13
|
Baile P, Vidal L, Canals A. Magnetic dispersive solid-phase extraction using ZSM-5 zeolite/Fe 2O 3 composite coupled with screen-printed electrodes based electrochemical detector for determination of cadmium in urine samples. Talanta 2020; 220:121394. [PMID: 32928414 DOI: 10.1016/j.talanta.2020.121394] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 07/06/2020] [Accepted: 07/07/2020] [Indexed: 10/23/2022]
Abstract
A novel, simple, fast, sensitive and environmentally friendly approach is presented to determine cadmium in urine samples, combining magnetic dispersive solid-phase extraction (MDSPE) for sample preparation and screen-printed carbon electrodes (SPCEs) for square-wave anodic stripping voltammetry. This association involves the miniaturization of sample preparation and measurement process. Firstly, cadmium was extracted directly from urine samples employing a ZSM-5/Fe2O3, then, the composite enriched with cadmium was deposited onto the SPCE and finally covered with a suitable electrolyte for electrochemical detection. Thereby, the elution and detection of cadmium were carried out in a single step. To optimize experimental parameters affecting MDSPE, a two-step multivariate strategy has been employed. The method has been evaluated under optimized extraction/elution conditions (i.e., type of sorbent, ZSM-5/Fe2O3; amount of sorbent, 10 mg; sample pH, 6.8; extraction time, 5.5 min; and HCl concentration, 0.5 M) using standard addition calibration. Standard addition calibration curves gave a good linearity in the range from 0 to 30 μg L-1 with correlation coefficients ranging from 0.997 to 0.998 (N = 7). The limit of detection, evaluated empirically and statistically, ranged from 0.5 to 1.0 μg L-1 and from 0.4 to 0.8 μg L-1, respectively, which are lower than the threshold level established by the Ministry of Labour and Social Affairs (Spain) and World Health Organization for normal cadmium content in urine (i.e., 3.4 and 4.0 μg L-1, respectively). The repeatability of the proposed method was evaluated at 5 and 20 μg L-1 spiking levels obtaining coefficients of variation ranged between 12 and 15% (n = 6). A certified reference material (REC-8848/Level II) was analyzed to assess method accuracy finding 92% and 1.3 μg L-1 as the recovery (trueness) and standard deviation values, respectively. Finally, the method was applied to spiked urine samples, obtaining good agreement between spiked and found concentrations (recovery ranged from 89 to 98% and CV values ranged from 7% to 14%). Therefore, this is a new and successful contribution to the portable total analytical systems.
Collapse
Affiliation(s)
- Paola Baile
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, E-03080, Alicante, Spain
| | - Lorena Vidal
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, E-03080, Alicante, Spain.
| | - Antonio Canals
- Departamento de Química Analítica, Nutrición y Bromatología e Instituto Universitario de Materiales, Universidad de Alicante, P.O. Box 99, E-03080, Alicante, Spain.
| |
Collapse
|
14
|
Todorova S, Blin J, Naydenov A, Lebeau B, Kolev H, Gaudin P, Dotzeva A, Velinova R, Filkova D, Ivanova I, Vidal L, Michelin L, Josien L, Tenchev K. Co3O4-MnOx oxides supported on SBA-15 for CO and VOCs oxidation. Catal Today 2020. [DOI: 10.1016/j.cattod.2019.05.018] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Frenel JS, Kim JW, Berton-Rigaud D, Asher R, Vidal L, Pautier P, Ledermann J, Penson R, Oza A, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon TW, Tamura K, Sonke G, Freimund A, Lee C, Pujade-Lauraine E. 813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.952] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
16
|
Curell A, Vidal L, Balibrea JM, Dopazo C, Charco R, Gómez-Gavara C. Pyogenic liver abscess: a complication after primary obesity surgery endolumenal (POSE) procedure. Surg Obes Relat Dis 2020; 16:1561-1562. [PMID: 32620377 DOI: 10.1016/j.soard.2020.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 05/02/2020] [Accepted: 05/05/2020] [Indexed: 11/26/2022]
Affiliation(s)
- A Curell
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - L Vidal
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | - C Dopazo
- Hospital Clínic de Barcelona, Barcelona, Spain
| | - R Charco
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | |
Collapse
|
17
|
Baile P, Medina J, Vidal L, Canals A. Determination of four bisphenols in water and urine samples by magnetic dispersive solid‐phase extraction using a modified zeolite/iron oxide composite prior to liquid chromatography diode array detection. J Sep Sci 2020; 43:1808-1816. [DOI: 10.1002/jssc.201901022] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Revised: 12/01/2019] [Accepted: 12/04/2019] [Indexed: 01/03/2023]
Affiliation(s)
- Paola Baile
- Departamento de Química AnalíticaNutrición y Bromatología e Instituto Universitario de MaterialesUniversidad de Alicante Alicante Spain
| | - Juan Medina
- Departamento de Química AnalíticaNutrición y Bromatología e Instituto Universitario de MaterialesUniversidad de Alicante Alicante Spain
| | - Lorena Vidal
- Departamento de Química AnalíticaNutrición y Bromatología e Instituto Universitario de MaterialesUniversidad de Alicante Alicante Spain
| | - Antonio Canals
- Departamento de Química AnalíticaNutrición y Bromatología e Instituto Universitario de MaterialesUniversidad de Alicante Alicante Spain
| |
Collapse
|
18
|
Vidal L, Berg R, Yang Z, Moss K. Participation of women in phase I oncology clinical trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz244.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
19
|
Peled A, Sarig O, Sun G, Samuelov L, Freeman A, Vidal L, Chamarthy L, Walter J, Milner J, Sprecher E. 350 Dual role of CARD14 in skin inflammatory diseases. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Rodilla Sala E, Colomer V, Perseguer Z, Jordá A, Jordá R, Prats R, García M, Vidal L, Sanchis M, Córcoles M, Mud F, Bellver O, Adell M, Ferrer F, Hernández M, Llopis T, Rodrigo M, Baixauli V, Climent M, Moreno L. DIFFERENCES IN AORTIC AUGMENTATION PRESSURE BETWEEN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS MEASURED IN COMMUNITY PHARMACIES IN SPAIN. J Hypertens 2019. [DOI: 10.1097/01.hjh.0000572696.06657.f1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Panciroli C, Lucente G, Vidal L, Carcereny E, Quiroga V, Pardo JC, Romeo M, Estival A, Manzano JL, Pardo B, Velarde JM, Esteve AM, Lopez D, Mañes A, Tuset V, Villà S, Quintero CB. Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab. Clin Transl Oncol 2019; 22:411-419. [PMID: 31144211 DOI: 10.1007/s12094-019-02143-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Accepted: 05/21/2019] [Indexed: 11/25/2022]
Abstract
PURPOSE We performed a cross-sectional study of neurocognitive function in non-brain cancer patients treated with long-term bevacizumab. METHODS/PATIENTS From 2015 to 2017, we included patients with different types of cancer treated with bevacizumab with or without chemotherapy (BEV; N = 20) or only chemotherapy (ChT; N = 19) for at least 34 weeks, patients who received non-brain radiotherapy (RxT; N = 19), and healthy controls (HC; N = 19) were assessed once at week 34 of treatment (BEV and ChT) or at completion of radiotherapy. Neurocognition was evaluated with the Hopkins Verbal Learning Test-Revised (HVLT-R) total and delayed recall, the Trail Making Test A and B, and the Controlled Oral Word Association Test in the four groups. Non-parametric tests were used to assess differences between groups. RESULTS The BEV, ChT, and RxT groups scored significantly lower than the HC group on all tests and especially on the HVLT-R total recall. In no case were the mean scores of the BEV group significantly lower than those of the ChT or RxT groups. CONCLUSIONS Neurocognitive impairment was seen even in patients treated with local non-brain radiotherapy. Treatment with bevacizumab for a long period of time does not seem to worsen neurocognitive function to a greater extent than chemotherapy.
Collapse
Affiliation(s)
- C Panciroli
- Badalona Applied Research Group in Oncology (B-ARGO Group) - Institut Investigació Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
- University of Barcelona (UB), Barcelona, Spain
| | - G Lucente
- Neurology Service - Neuroscience Department, Hospital Germans Trias i Pujol - Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Barcelona, Spain
- Universitat Automa de Barcelona (UAB), Bellaterra, Barcelona, Spain
| | - L Vidal
- Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain
| | - E Carcereny
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - V Quiroga
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - J C Pardo
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - M Romeo
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - A Estival
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - J L Manzano
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - B Pardo
- Medical Oncology Service, Hospital Duran i Reynals - Institut Catalá d'Oncologia (ICO), Barcelona, Spain
| | - J M Velarde
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - A M Esteve
- Tumor Hospital Registry, Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - D Lopez
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - A Mañes
- Radiation Oncology Service, Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - V Tuset
- Radiation Oncology Service, Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - S Villà
- Radiation Oncology Service, Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain
| | - C B Quintero
- Medical Oncology Service - Badalona Applied Research Group in Oncology (B-ARGO Group), Hospital Germans Trias i Pujol - Institut Catalá d'Oncologia (ICO), Badalona, Barcelona, Spain.
| |
Collapse
|
22
|
|
23
|
Core J, Pham T, Bailey R, Vidal L, Bussone S, Sturchio G, LeGout J, Sharma A, Jain M, McKinney J, Ritchie C, Paz-Fumagalli R, Lewis A, Frey G, Toskich B. 03:18 PM Abstract No. 114 A single-center experience with proximal radioembolization enabled by distal angiosomal truncation (PREDATr). J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
24
|
Ahmed A, Paz-Fumagalli R, McKinney J, Ritchie C, Frey G, Lewis A, Devcic Z, Livingston D, Cheiky E, Vega L, Hodge D, Vidal L, Shah J, Geller B, Kolarich A, Wang M, Alvarado C, Iv C, Lubinski A, Toskich B. 03:09 PM Abstract No. 113 Lobar Yttrium-90 transarterial radioembolization equal or greater than 150Gy MIRD: an analysis of hepatic biochemical safety as a function of treated liver volume and administered dose. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
25
|
Abstract
This review presents an overview of the current status of zeolites and zeolite-based materials used in extraction and microextraction techniques with reference to recent applications and highlight some of the novel advances.
Collapse
Affiliation(s)
- Paola Baile
- Departamento de Química Analítica
- Nutrición y Bromatología e Instituto Universitario de Materiales
- Universidad de Alicante
- E-03080 Alicante
- Spain
| | - Elena Fernández
- Departamento de Química Analítica
- Nutrición y Bromatología e Instituto Universitario de Materiales
- Universidad de Alicante
- E-03080 Alicante
- Spain
| | - Lorena Vidal
- Departamento de Química Analítica
- Nutrición y Bromatología e Instituto Universitario de Materiales
- Universidad de Alicante
- E-03080 Alicante
- Spain
| | - Antonio Canals
- Departamento de Química Analítica
- Nutrición y Bromatología e Instituto Universitario de Materiales
- Universidad de Alicante
- E-03080 Alicante
- Spain
| |
Collapse
|
26
|
Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C. Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM). HIV Med 2018; 20:38-46. [PMID: 30362279 DOI: 10.1111/hiv.12681] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/15/2018] [Indexed: 11/30/2022]
Abstract
OBJECTIVES In terms of HIV infection, western and central Africa is the second most affected region world-wide, and the gap between the regional figures for the testing and treatment cascade and the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets is particularly worrying. We assessed the prevalence of virological suppression in patients routinely treated in 19 hospitals in Cameroon. METHODS A cross-sectional survey was performed in adult patients receiving antiretroviral therapy (ART) in the Centre and Littoral regions. The prevalences of virological suppression (<1000 HIV-1 RNA copies/mL) were compared among all 19 hospitals using the χ2 test. Potential individual and health care-related determinants of virological suppression were assessed using multivariate logistic regression models. RESULTS A total of 1700 patients (74% women; median age 41 years; median time on ART 3.7 years) were included in the study. The prevalence of virological suppression was 82.4% overall (95% confidence interval 80.5-84.2%). It ranged from 57.1 to 97.4% according to the individual hospital (P < 0.001). After adjustment, virological suppression was associated with age, CD4 cell count at ART initiation, disclosure of HIV status to family members, interruption of ART for more than two consecutive days, and location of patient's residence and hospital (rural/urban). These factors did not explain the heterogeneity of virological suppression between the study hospitals (P < 0.001). CONCLUSIONS The overall prevalence of virological suppression was reassuring. Nevertheless, the heterogeneity of virological suppression among hospitals highlights that, in addition to programme-level data, health facility-level data are crucial in order to tailor the national AIDS programme's interventions with a view to achieving the third UNAIDS 90 target.
Collapse
Affiliation(s)
- F Liégeois
- IRD, INSERM, University of Montpellier, TransVIHMI, Montpellier, France.,CREMER, Yaoundé, Cameroon
| | - S Eymard-Duvernay
- IRD, INSERM, University of Montpellier, TransVIHMI, Montpellier, France
| | - S Boyer
- INSERM, IRD, University of Aix-Marseille, SESSTIM, Marseille, France
| | - G Maradan
- INSERM, IRD, University of Aix-Marseille, SESSTIM, Marseille, France
| | | | | | - V Boyer
- IRD, INSERM, University of Montpellier, TransVIHMI, Montpellier, France
| | | | - B Spire
- INSERM, IRD, University of Aix-Marseille, SESSTIM, Marseille, France
| | - E Delaporte
- IRD, INSERM, University of Montpellier, TransVIHMI, Montpellier, France
| | - L Vidal
- INSERM, IRD, University of Aix-Marseille, SESSTIM, Marseille, France
| | - C Kuaban
- Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
| | - C Laurent
- IRD, INSERM, University of Montpellier, TransVIHMI, Montpellier, France
| | | |
Collapse
|
27
|
Costa dos Reis L, Vidal L, Canals A. Determination of siloxanes in water samples employing graphene oxide/Fe3
O4
nanocomposite as sorbent for magnetic solid-phase extraction prior to GC-MS. J Sep Sci 2018; 41:4177-4184. [DOI: 10.1002/jssc.201800577] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2018] [Revised: 08/27/2018] [Accepted: 09/12/2018] [Indexed: 12/22/2022]
Affiliation(s)
- Luciana Costa dos Reis
- Departamento de Química Analítica; Nutrición y Bromatología e Instituto Universitario de Materiales; Universidad de Alicante; Alicante Spain
- CAPES Foundation; Ministry of Education of Brazil; Brasília DF Brazil
| | - Lorena Vidal
- Departamento de Química Analítica; Nutrición y Bromatología e Instituto Universitario de Materiales; Universidad de Alicante; Alicante Spain
| | - Antonio Canals
- Departamento de Química Analítica; Nutrición y Bromatología e Instituto Universitario de Materiales; Universidad de Alicante; Alicante Spain
| |
Collapse
|
28
|
Abellán-Llobregat A, Vidal L, Rodríguez-Amaro R, Canals A, Morallón E. Evaluation of herringbone carbon nanotubes-modified electrodes for the simultaneous determination of ascorbic acid and uric acid. Electrochim Acta 2018. [DOI: 10.1016/j.electacta.2018.08.007] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Abellán-Llobregat A, González-Gaitán C, Vidal L, Canals A, Morallón E. Portable electrochemical sensor based on 4-aminobenzoic acid-functionalized herringbone carbon nanotubes for the determination of ascorbic acid and uric acid in human fluids. Biosens Bioelectron 2018; 109:123-131. [DOI: 10.1016/j.bios.2018.02.047] [Citation(s) in RCA: 43] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 02/13/2018] [Accepted: 02/20/2018] [Indexed: 02/07/2023]
|
30
|
Fernández E, Vidal L, Canals A. Rapid determination of hydrophilic phenols in olive oil by vortex-assisted reversed-phase dispersive liquid-liquid microextraction and screen-printed carbon electrodes. Talanta 2018; 181:44-51. [DOI: 10.1016/j.talanta.2017.12.075] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2017] [Revised: 12/19/2017] [Accepted: 12/22/2017] [Indexed: 12/24/2022]
|
31
|
Portilho-Ramos RC, Cruz APS, Barbosa CF, Rathburn AE, Mulitza S, Venancio IM, Schwenk T, Rühlemann C, Vidal L, Chiessi CM, Silveira CS. Methane release from the southern Brazilian margin during the last glacial. Sci Rep 2018; 8:5948. [PMID: 29654329 PMCID: PMC5899165 DOI: 10.1038/s41598-018-24420-0] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2017] [Accepted: 03/26/2018] [Indexed: 11/09/2022] Open
Abstract
Seafloor methane release can significantly affect the global carbon cycle and climate. Appreciable quantities of methane are stored in continental margin sediments as shallow gas and hydrate deposits, and changes in pressure, temperature and/or bottom-currents can liberate significant amounts of this greenhouse gas. Understanding the spatial and temporal dynamics of marine methane deposits and their relationships to environmental change are critical for assessing past and future carbon cycle and climate change. Here we present foraminiferal stable carbon isotope and sediment mineralogy records suggesting for the first time that seafloor methane release occurred along the southern Brazilian margin during the last glacial period (40-20 cal ka BP). Our results show that shallow gas deposits on the southern Brazilian margin responded to glacial-interglacial paleoceanographic changes releasing methane due to the synergy of sea level lowstand, warmer bottom waters and vigorous bottom currents during the last glacial period. High sea level during the Holocene resulted in an upslope shift of the Brazil Current, cooling the bottom waters and reducing bottom current strength, reducing methane emissions from the southern Brazilian margin.
Collapse
Affiliation(s)
- R C Portilho-Ramos
- MARUM - Center for Marine Environmental Sciences, University of Bremen, Leobener Strasse, 28359, Bremen, Germany. .,Programa de Pós Graduação em Geoquímica, Universidade Federal Fluminense, Outeiro São João Batista S/N, 24020-141, Niterói RJ, Brazil. .,Institute of Geosciences, University of São Paulo, Rua do Lago 562, 05508-080, São Paulo SP, Brazil.
| | - A P S Cruz
- Programa de Pós Graduação em Geoquímica, Universidade Federal Fluminense, Outeiro São João Batista S/N, 24020-141, Niterói RJ, Brazil
| | - C F Barbosa
- Programa de Pós Graduação em Geoquímica, Universidade Federal Fluminense, Outeiro São João Batista S/N, 24020-141, Niterói RJ, Brazil
| | - A E Rathburn
- Department of Geological Sciences, California State University Bakersfield, 9001 Stockdale Highway, Bakersfield, CA, USA
| | - S Mulitza
- MARUM - Center for Marine Environmental Sciences, University of Bremen, Leobener Strasse, 28359, Bremen, Germany
| | - I M Venancio
- Center for Weather Forecasting and Climate Studies (CPTEC), National Institute for Space Research (INPE), Cachoeira Paulista, Brazil
| | - T Schwenk
- MARUM - Center for Marine Environmental Sciences, University of Bremen, Leobener Strasse, 28359, Bremen, Germany
| | - C Rühlemann
- BGR - Federal Institute for Geosciences and Natural Resources, Stilleweg 2, 30655, Hannover, Germany
| | - L Vidal
- Aix-Marseille University, CNRS, IRD, CEREGE UM34, 13545, Aix-en-Provence, France
| | - C M Chiessi
- School of Arts, Sciences and Humanities, University of São Paulo, Av. Arlindo Béttio 1000, 03828-000, São Paulo SP, Brazil
| | - C S Silveira
- Programa de Pós Graduação em Geoquímica, Universidade Federal Fluminense, Outeiro São João Batista S/N, 24020-141, Niterói RJ, Brazil
| |
Collapse
|
32
|
Mayoral M, Paredes P, Saco A, Fusté P, Perlaza P, Tapias A, Fernandez-Martinez A, Vidal L, Ordi J, Pavia J, Martinez-Roman S, Lomeña F. Correlación de la captación de 18 F-FDG de la PET/TC con el Ki67 de la inmunohistoquímica en el cáncer epitelial de ovario pretratamiento. Rev Esp Med Nucl Imagen Mol 2018. [DOI: 10.1016/j.remnie.2017.10.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
33
|
Salvá P, Vidal L, Ribas M, Sáez de Ibarra J, Pericas P, Padrol D, Caldés O, Ruiz de Gopegui E, Martin J, Riera M. Experiencia en nuestro centro de endocarditis infecciosa aguda en pacientes cirróticos. Cirugía Cardiovascular 2018. [DOI: 10.1016/j.circv.2017.12.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
34
|
Vidal L, Padrol D, Salvà P, Ruiz de Gopegui E, Tarrío R, Enriquez F, Pericàs P, Ribas M, Riera M, Sáez de Ibarra J. Reparación vs sustitución valvular mitral en endocarditis infecciosa aguda. Experiencia de nuestro centro. Cirugía Cardiovascular 2018. [DOI: 10.1016/j.circv.2017.12.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
35
|
Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. Clin Microbiol Infect 2017; 24:749-754. [PMID: 29208561 DOI: 10.1016/j.cmi.2017.11.019] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Revised: 11/14/2017] [Accepted: 11/22/2017] [Indexed: 11/19/2022]
Abstract
OBJECTIVES We aimed to study whether ciprofloxacin prophylaxis reduces infectious complications in patients undergoing autologous haematopoietic cell transplantation (AHCT). METHODS This is a quasi-experimental, retrospective, before-after study. We compared the incidence of bacterial-related complications among 356 patients with multiple myeloma (MM) (n = 202) and lymphoma (n = 154) who underwent AHCT with (n = 177) or without (n = 179) ciprofloxacin prophylaxis between 03/2007 and 10/2012 and between 10/2012 and 07/2016, respectively, at a single centre. RESULTS Febrile neutropaenia, bacteraemia, and pneumonia were significantly more common among patients who underwent AHCT during the second study period and did not receive antibacterial prophylaxis compared with patients who underwent AHCT during the first study period and received antibacterial prophylaxis (89.9% (161/179) vs. 83.1% (147/177), difference 6.9%, 95% CI 0-14.1%, P = 0.002; 15.1% (27/179) vs. 4.5% (8/177), difference 10.6%, 95% CI 4.4-16.9%, p < 0.0001; 12.3% (22/179) vs. 6.2% (11/177), difference 6.1%, 95% CI 0-12.3%, p = 0.04, respectively). The number-needed-to-treat to prevent one episode of bacteraemia, pneumonia, and febrile neutropaenia was 8.6, 8.5, and 13.7, respectively. Patients with ciprofloxacin prophylaxis had higher rates of ciprofloxacin-resistant bacteraemia (62.5% (5/8) vs. 18.5% (5/27), difference 44%, 95% CI 7-70%, p = 0.01). In multivariate analysis, ciprofloxacin prophylaxis significantly decreased the odds of bacteraemia (OR 0.19, 95% CI 0.07-0.52; p < 0.0001) and pneumonia (OR 0.37, 95% CI 0.16-0.85, p = 0.02). CONCLUSION According to our single-centre experience, patients with MM and lymphoma undergoing AHCT may benefit from antibacterial prophylaxis with ciprofloxacin.
Collapse
Affiliation(s)
- M Yeshurun
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
| | - I Vaxman
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - L Shargian
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - D Yahav
- Infectious Diseases Unit, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - J Bishara
- Infectious Diseases Unit, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - O Pasvolsky
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - O Wolach
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - M Lahav
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - R Gurion
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - H Magen
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - L Vidal
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - C Herscovici
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - A Peck
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel
| | - M Moshe
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel
| | - M Sela-Navon
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel
| | - E Naparstek
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - P Raanani
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - U Rozovski
- Institute of Haematology, Davidoff Cancer Centre, Rabin Medical Centre, Petah Tikva, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|
36
|
Jaeger S, Vidal L, Kam K, Ares G. Corrigendum to “Can emoji be used as a direct method to measure emotional associations to food names? Preliminary investigations with consumers in USA and China” [Food Qual. Preference 56 (2017) 38–48]. Food Qual Prefer 2017. [DOI: 10.1016/j.foodqual.2016.11.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
Vidal L, Mangas A, Geffard M. A new therapeutic approach to auto-immune diseases: Endotherapia. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx509.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Mayoral M, Paredes P, Saco A, Fusté P, Perlaza P, Tapias A, Fernandez-Martinez A, Vidal L, Ordi J, Pavia J, Martinez-Roman S, Lomeña F. Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer. Rev Esp Med Nucl Imagen Mol 2017; 37:80-86. [PMID: 28869177 DOI: 10.1016/j.remn.2017.07.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2017] [Revised: 06/18/2017] [Accepted: 07/09/2017] [Indexed: 01/10/2023]
Abstract
OBJECTIVE Standardised uptake value (SUV) and volumetric parameters such as metabolic tumour volume (MTV) and total lesion glycolysis (TLG) from 18F-FDG PET/CT are useful criteria for disease prognosis in pre-operative and post-treatment epithelial ovarian cancer (EOC). Ki67 is another prognostic biomarker in EOC, associated with tumour aggressiveness. The aim of this study is to evaluate the association between 18F-FDG PET/CT measurements and Ki67 in pre-treatment EOC to determine if PET/CT parameters could non-invasively predict tumour aggressiveness. MATERIAL AND METHODS A pre-treatment PET/CT was performed on 18 patients with suspected or newly diagnosed EOC. Maximum SUV (SUVmax), mean SUV (SUVmean), whole-body MTV (wbMTV), and whole-body TLG (wbTLG) with a threshold of 30% and 40% of the SUVmax were obtained. Furthermore, Ki67 index (mean and hotspot) was estimated in tumour tissue specimens. Immunohistochemical findings were correlated with PET parameters. RESULTS The mean age was 57.0 years old (standard deviation 13.6 years). A moderate correlation was observed between mean Ki67 index and SUVmax (r=0.392), SUVmean 30% (r=0.437), and SUVmean 40% (r=0.443), and also between hotspot Ki67 index and SUVmax (r=0.360), SUVmean 30% (r=0.362) and SUVmean 40% (r=0.319). There was a weaker correlation, which was inversely negative, between mean and hotspot Ki67 and volumetric PET parameters. However, no statistical significant differences were found for any correlations. CONCLUSIONS SUVmax and SUVmean were moderately correlated with Ki67 index, whereas volumetric PET parameters overall, showed a weaker correlation. Thus, SUVmax and SUVmean could be used to assess tumour aggressiveness in pre-treatment EOC.
Collapse
Affiliation(s)
- M Mayoral
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain
| | - P Paredes
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
| | - A Saco
- Department of Pathology, Hospital Clínic, Barcelona, Spain
| | - P Fusté
- Gynaecology Department, Hospital Clínic, Barcelona, Spain
| | - P Perlaza
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain
| | - A Tapias
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain
| | | | - L Vidal
- Medical Oncology Department, Hospital Clínic, Barcelona, Spain
| | - J Ordi
- Department of Pathology, Hospital Clínic, Barcelona, Spain; Centre de Recerca en Salut Internacional de Barcelona (CRESIB), Barcelona, Spain
| | - J Pavia
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain
| | - S Martinez-Roman
- Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Gynaecology Department, Hospital Clínic, Barcelona, Spain
| | - F Lomeña
- Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
| |
Collapse
|
39
|
Vidal L, Ahmadi M, Fernández E, Madrakian T, Canals A. Magnetic headspace adsorptive extraction of chlorobenzenes prior to thermal desorption gas chromatography-mass spectrometry. Anal Chim Acta 2017; 971:40-47. [DOI: 10.1016/j.aca.2017.04.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Revised: 03/29/2017] [Accepted: 04/01/2017] [Indexed: 01/26/2023]
|
40
|
Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R. The role of maintenance therapy in patients with diffuse large B-cell lymphoma: A systematic review and meta-analysis. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_85] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- A. Rozental
- Hematology Division; Davidoff Cancer Center, Rabin Medical Center; Petah-Tikva Israel
| | - A. Gafter-Gvili
- Hematology Division; Davidoff Cancer Center, Rabin Medical Center; Petah-Tikva Israel
| | - L. Vidal
- Hematology Division; Davidoff Cancer Center, Rabin Medical Center; Petah-Tikva Israel
| | - P. Raanani
- Hematology Division; Davidoff Cancer Center, Rabin Medical Center; Petah-Tikva Israel
| | - R. Gurion
- Hematology Division; Davidoff Cancer Center, Rabin Medical Center; Petah-Tikva Israel
| |
Collapse
|
41
|
Amitai I, Gurion R, Vidal L, Dann E, Raanani P, Gafter-Gvili A. PET-CT-adapted therapy for advanced Hodgkin lymphoma: A systematic review of the literature. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- I. Amitai
- Institute of Hematology; Rabin Medical Center; Petah Tikva Israel
| | - R. Gurion
- Institute of Hematology; Rabin Medical Center; Petah Tikva Israel
| | - L. Vidal
- Institute of Hematology; Rabin Medical Center; Petah Tikva Israel
| | - E.J. Dann
- Department of Hematology and Bone Marrow Transplantation; Rambam Health Care Campus; Haifa Israel
| | - P. Raanani
- Institute of Hematology; Rabin Medical Center; Petah Tikva Israel
| | - A. Gafter-Gvili
- Institute of Hematology; Rabin Medical Center; Petah Tikva Israel
| |
Collapse
|
42
|
Gurion R, Bernstein H, Vidal L, Raanani P, Gafter-Gvili A. THE VALUE OF PET/CT IN DETECTING BONE MARROW INVOLVEMENT IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- R. Gurion
- Hematology Institute; Rabin Medical Center; Petach Tikva Israel
| | - H. Bernstein
- Department of Nuclear Medicine; Rabin Medical Center; Petach Tikva Israel
| | - L. Vidal
- Hematology Institute; Rabin Medical Center; Petach Tikva Israel
| | - P. Raanani
- Hematology Institute; Rabin Medical Center; Petach Tikva Israel
| | - A. Gafter-Gvili
- Hematology Institute; Rabin Medical Center; Petach Tikva Israel
| |
Collapse
|
43
|
Abellán-Llobregat A, Jeerapan I, Bandodkar A, Vidal L, Canals A, Wang J, Morallón E. A stretchable and screen-printed electrochemical sensor for glucose determination in human perspiration. Biosens Bioelectron 2017; 91:885-891. [PMID: 28167366 PMCID: PMC5328638 DOI: 10.1016/j.bios.2017.01.058] [Citation(s) in RCA: 165] [Impact Index Per Article: 23.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2016] [Revised: 01/13/2017] [Accepted: 01/25/2017] [Indexed: 02/08/2023]
Abstract
Here we present two types of all-printable, highly stretchable, and inexpensive devices based on platinum (Pt)-decorated graphite for glucose determination in physiological fluids. Said devices are: a non-enzymatic sensor and an enzymatic biosensor, the latter showing promising results. Glucose has been quantified by measuring hydrogen peroxide (H2O2) reduction by chronoamperometry at -0.35V (vs pseudo-Ag/AgCl) using glucose oxidase immobilized on Pt-decorated graphite. The sensor performs well for the quantification of glucose in phosphate buffer solution (0.25M PBS, pH 7.0), with a linear range between 0 mM and 0.9mM, high sensitivity and selectivity, and a low limit of detection (LOD). Thus, it provides an alternative non-invasive and on-body quantification of glucose levels in human perspiration. This biosensor has been successfully applied on real human perspiration samples and results also show a significant correlation between glucose concentration in perspiration and glucose concentration in blood measured by a commercial glucose meter.
Collapse
Affiliation(s)
- A Abellán-Llobregat
- Instituto Universitario de Materiales, Universidad de Alicante, Apartado 99, 03080 Alicante, Spain
| | - Itthipon Jeerapan
- Department of NanoEngineering, University of California, La Jolla, San Diego, CA 92093, USA
| | - A Bandodkar
- Department of NanoEngineering, University of California, La Jolla, San Diego, CA 92093, USA
| | - L Vidal
- Departamento de Química Analítica, Nutrición y Bromatología and Instituto Universitario de Materiales, Universidad de Alicante, Apartado 99, 03080 Alicante, Spain
| | - A Canals
- Departamento de Química Analítica, Nutrición y Bromatología and Instituto Universitario de Materiales, Universidad de Alicante, Apartado 99, 03080 Alicante, Spain
| | - J Wang
- Department of NanoEngineering, University of California, La Jolla, San Diego, CA 92093, USA
| | - E Morallón
- Instituto Universitario de Materiales, Universidad de Alicante, Apartado 99, 03080 Alicante, Spain
| |
Collapse
|
44
|
Abellán-Llobregat A, Vidal L, Rodríguez-Amaro R, Berenguer-Murcia Á, Canals A, Morallón E. Au-IDA microelectrodes modified with Au-doped graphene oxide for the simultaneous determination of uric acid and ascorbic acid in urine samples. Electrochim Acta 2017. [DOI: 10.1016/j.electacta.2016.12.132] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
45
|
Alfon J, Vidal L, Gaba L, Victoria I, Gil M, Laquente B, Brunet M, Colom H, Ramis J, Perez-Montoyo H, Cortal M, Gomez-Ferreria M, Muñoz P, Erazo T, Lizcano J, Domenech C, Gascon P. Determination of recommended phase II dose of ABTL0812, a novel regulator of Akt/mTOR axis, by pharmacokinetic-pharmacodynamic modelling. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw368.21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Vidal L, Joussein E, Colas M, Cornette J, Sanz J, Sobrados I, Gelet JL, Absi J, Rossignol S. Controlling the reactivity of silicate solutions: A FTIR, Raman and NMR study. Colloids Surf A Physicochem Eng Asp 2016. [DOI: 10.1016/j.colsurfa.2016.05.039] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Stanovici J, Le Nail LR, Brennan MA, Vidal L, Trichet V, Rosset P, Layrolle P. Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery. Curr Res Transl Med 2016; 64:83-90. [PMID: 27316391 DOI: 10.1016/j.retram.2016.04.006] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Revised: 04/13/2016] [Accepted: 04/14/2016] [Indexed: 12/18/2022]
Abstract
Bone is the most transplanted tissue human with 1 million procedures every year in Europe. Surgical interventions for bone repair are required for varied reasons such as trauma resulting non-union fractures, or diseases including osteoporosis or osteonecrosis. Autologous bone grafting is the gold standard in bone regeneration but it requires a second surgery with associated pain and complications, and is also limited by harvested bone quantity. Synthetic bone substitutes lack the osteoinductive properties to heal large bone defects. Cell therapies based on bone marrow or ex vivo expanded mesenchymal stromal stem cells (MSCs) in association with synthetic calcium phosphate (CaP) bone substitutes may be alternatives to autologous bone grafting. This manuscript reviews the different conventional biological and synthetic bone grafting procedures as well as the more recently introduced cell therapy approaches used in orthopaedic surgery for bone regeneration. Some clinical studies have demonstrated safety and efficacy of these approaches but regeneration of large bone defects remain challenging due to the absence of rapid and adequate vascularisation. Future directions in the field of bone regeneration are presented, such as testing alternative cell sources or in situ fabrication of vascularized bone grafts in patients.
Collapse
Affiliation(s)
- J Stanovici
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France; Service de chirurgie orthopédique et traumatologique 2, hôpital Trousseau, CHRU de Tours, 37044 Tours, France
| | - L-R Le Nail
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France; Service de chirurgie orthopédique et traumatologique 2, hôpital Trousseau, CHRU de Tours, 37044 Tours, France
| | - M A Brennan
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France
| | - L Vidal
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France
| | - V Trichet
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France
| | - P Rosset
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France; Service de chirurgie orthopédique et traumatologique 2, hôpital Trousseau, CHRU de Tours, 37044 Tours, France
| | - P Layrolle
- Inserm, UMR 957, équipe labellisée Ligue 2012, 1, rue Gaston-Veil, 44035 Nantes, France; Laboratoire de physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, faculté de médecine, université de Nantes, Nantes Atlantique universités, 1, rue Gaston-Veil, 44035 Nantes, France; Service de chirurgie orthopédique et traumatologique 2, hôpital Trousseau, CHRU de Tours, 37044 Tours, France.
| |
Collapse
|
48
|
Fernández E, Vidal L, Costa-García A, Canals A. Mercury determination in urine samples by gold nanostructured screen-printed carbon electrodes after vortex-assisted ionic liquid dispersive liquid–liquid microextraction. Anal Chim Acta 2016; 915:49-55. [DOI: 10.1016/j.aca.2016.02.028] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Revised: 02/17/2016] [Accepted: 02/22/2016] [Indexed: 10/22/2022]
|
49
|
Mayoral M, Fernandez-Martinez A, Vidal L, Fuster D, Aya F, Pavia J, Pons F, Lomeña F, Paredes P. Prognostic value of 18 F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer. Rev Esp Med Nucl Imagen Mol 2016. [DOI: 10.1016/j.remnie.2016.01.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Partovi S, Vidal L, Nakamoto D, Lu Z, Buethe J, Coffey M, Patel I. Lymphatic malformation treatment in adult and pediatric populations using real-time MRI guided percutaneous sclerotherapy. J Vasc Interv Radiol 2016. [DOI: 10.1016/j.jvir.2015.12.570] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|